insights_auto
Por que KLBF caiu 2,55%?
Saiba maischevron_right
KLBF:IDX
Kalbe Farma Tbk PT
IDR 765,00
arrow_downward
-2,55%(-20,00) 1D
12 de out., 16:13:55 GMT+7 · IDR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para KLBF…
Abrir
IDR 785
Alta
IDR 800
Baixa
IDR 760
Valor de mercado
35,81 tri
Volume médio
66,61 mi
Volume
44,51 mi
Dividendo
2,61%
Dividendo trimestral
IDR 5
Data de ex-dividendo
4 de jun. de 2026
Índice P/L
9,61
Alto — 52 sem
IDR 1.345
Baixo — 52 sem
IDR 630
LPA
IDR 80
Ações em circulação
46,81 bi
Nº de funcionários
13 mil
Abrir
IDR 785
Alta
IDR 800
Baixa
IDR 760
Valor de mercado
35,81 tri
Volume médio
66,61 mi
Volume
44,51 mi
Dividendo
2,61%
Dividendo trimestral
IDR 5
Data de ex-dividendo
4 de jun. de 2026
Índice P/L
9,61
Alto — 52 sem
IDR 1.345
Baixo — 52 sem
IDR 630
LPA
IDR 80
Ações em circulação
46,81 bi
Nº de funcionários
13 mil
Notícias
De fontes da web e parceiros de notícias
ad-hoc-news.de
·
há 6 horas
Kalbe Farma stock at EUR 0.04 with IDR 34.6 trillion market cap
ad-hoc-news.de
·
há 9 horas
UBS keeps IDR 1,100 target for Kalbe Farma stock
ad-hoc-news.de
·
há 1 dia
Kalbe Farma stock holds EUR 0.04 with a EUR 0.04 weekly range
AD HOC NEWS
·
há 2 dias
Kalbe Farma stock is unchanged at EUR 0.04 in weekend trading
Perfil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Sobre Kalbe Farma Tbk PT